| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2000PNAS...97.3503T |
| P356 | DOI | 10.1073/PNAS.070521097 |
| 10.1073/PNAS.97.7.3503 | ||
| P932 | PMC publication ID | 16269 |
| P698 | PubMed publication ID | 10725407 |
| P50 | author | Guido Ferrari | Q56481169 |
| Simon F Lacey | Q56978267 | ||
| Kent J. Weinhold | Q109935303 | ||
| P2093 | author name string | G D Tomaras | |
| M L Greenberg | |||
| C B McDanal | |||
| P2860 | cites work | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 |
| A new classification for HIV-1 | Q22251292 | ||
| The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry | Q24315492 | ||
| Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters | Q24315645 | ||
| A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family | Q24337205 | ||
| Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
| Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection | Q28304764 | ||
| Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection | Q28304773 | ||
| Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist | Q28325213 | ||
| The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 | Q29616093 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes | Q29619514 | ||
| CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual | Q34185306 | ||
| CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 | ||
| CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription | Q34585299 | ||
| Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms | Q35881271 | ||
| Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines | Q35886502 | ||
| The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1. | Q36576683 | ||
| CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages | Q37093363 | ||
| Co-receptors for HIV-1 entry | Q39265878 | ||
| Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects | Q39412767 | ||
| HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication | Q39583378 | ||
| Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness | Q40067319 | ||
| Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. | Q40971485 | ||
| IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). | Q40977801 | ||
| Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual | Q41047644 | ||
| Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans | Q41060711 | ||
| Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific | Q41276077 | ||
| Noncytolytic CD8 T cell-mediated suppression of HIV replication | Q41413246 | ||
| Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? | Q41552550 | ||
| Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates | Q41571158 | ||
| HIV entry and tropism: the chemokine receptor connection. | Q41694886 | ||
| A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion | Q42560226 | ||
| CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. | Q42813563 | ||
| Studies in subjects with long-term nonprogressive human immunodeficiency virus infection | Q44369963 | ||
| HIV-specific cytotoxic T lymphocytes in seropositive individuals | Q59098667 | ||
| HIV infection in recipients of blood products from donors with known duration of infection | Q72690746 | ||
| CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism | Q72782422 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3503-3508 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression | |
| P478 | volume | 97 |
| Q33326188 | A cell-penetrating helical peptide as a potential HIV-1 inhibitor |
| Q30596957 | A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection. |
| Q34356962 | A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation |
| Q36315550 | Analysis of the interaction of primate retroviruses with the human RNA interference machinery |
| Q35020718 | CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition |
| Q30397667 | CD8(+)T-cell-mediated control of HIV-1 and SIV infection |
| Q37686094 | CD8+ T cell control of HIV--a known unknown. |
| Q40722440 | Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression |
| Q33927681 | Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection |
| Q35752416 | Control of HIV-1 infection by soluble factors of the immune response |
| Q47205468 | Dendritic cells efficiently transmit HIV to T Cells in a tenofovir and raltegravir insensitive manner. |
| Q59351146 | Detailed Characterization of Early HIV-1 Replication Dynamics in Primary Human Macrophages |
| Q34535266 | Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses |
| Q36876345 | Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication |
| Q40794254 | Exploring the benefits of antibody immune response in HIV-1 infection using a discrete model. |
| Q91902646 | HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers |
| Q35130519 | Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses |
| Q33842286 | Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques |
| Q36086631 | Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication |
| Q37175151 | Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppression |
| Q50087578 | Mechanisms of CD8+ T cell-mediated suppression of HIV/SIV replication. |
| Q34632063 | New hope for an AIDS vaccine |
| Q39606897 | Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines |
| Q37157103 | Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells |
| Q33826974 | Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination |
| Q34059524 | Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression |
| Q33778466 | Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution |
| Q39020001 | Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor |
| Q36738008 | Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage |
| Q27319151 | Single-Cell and Single-Cycle Analysis of HIV-1 Replication |
| Q34348561 | Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges |
| Q34593086 | Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies |
| Q33806166 | Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses r |
| Q38973028 | The CD8 antiviral factor (CAF) can suppress HIV-1 transcription from the long terminal repeat (LTR) promoter in the absence of elements upstream of the CATATAA box. |
| Q36635233 | The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells |
| Q34059605 | Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition |
| Q27313589 | Vaccination-induced noncytolytic effects in the acute phase of SHIV infection |
| Q46627893 | α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors |
Search more.